https://www.bccresearch.com/index/rss/code/pharmaceuticalshttps://www.bccresearch.com/public/public/images2017/logo.png https://www.bccresearch.com/index/rss/code/pharmaceuticalsPharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.en-usN/Ainfo@bccresearch.com 30Copyright (C) 2022 bccresearch.comThe global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/otc-drugs-vitamins-dietary-supplements-markets.htmlThis report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/pharmaceutical-drugs-industry-competitive-landscape.htmlThe global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029.andnbsp; The North American influenza market is expected to grow from $4.5.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/the-global-influenza-market.htmlThe global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/liver-disease-treatments-global-market-report.htmlThe global cancer immunotherapy market is expected to grow from $144.2 billion in 2024 and is projected to reach $247.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.4% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/cancer-immunotherapy-market.htmlThe report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/nanotechnology-cancer-treatment-market-report.htmlThe global radiopharmaceuticals market is expected to grow from $10.3 billion in 2024 and is projected to reach $21.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 16.4% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/radiopharmaceuticals-technologies-markets-report.htmlThe global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-cancer-therapeutics-market-emphasis-on-recurrent-and-metastatic-divisions-report.htmlThe global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/personalized-medicine-epigenomics-tech-markets-report.htmlThe global market for high-throughput screening is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/high-throughput-screening-technologies-global-markets.htmlThe global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/neurology-market-research-report.htmlThe global market for drugs of abuse (DOA) testing is estimated to increase from $5.2 billion in 2022 to reach $8.1 billion by 2027, at a compound annual growth rate (CAGR) of 9.3% from 2022 through 2027.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/pharmaceuticals-research-review.htmlThe global market for Alzheimerandrsquo;s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/alzheimers-disease-therapeutics-diagnostics-markets-report.htmlThe global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/laboratory-animal-models-3D-cultures-organoids.htmlThe global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/rare-disease-diagnostics-market-report.htmlThe global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/breakthrough-therapies-market-report.htmlThe global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/softgel-capsules-market.htmlThe global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-cdmo-market.htmlThe global market for active pharmaceutical ingredients (APIs) is estimated to increase from $247.8 billion in 2023 to reach $347.9 billion by 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/active-pharmaceutical-ingredients-global-markets.htmlThe global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-market-for-contract-research-organization-cro-services.htmlThe global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/oncology-pharmaceuticals-market.htmlThe global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.6 billion in 2024 to $12.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/excipients-in-pharmaceuticals-global-markets.htmlThe global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to reach $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/antibody-drug-conjugates-markets-report.htmlThe global market for contract pharmaceutical manufacturing, research and packaging is estimated to increase from $212.2 billion in 2023 to reach $310.2 billion by 2029, at a compound annual growth rate (CAGR) of 6.7% from 2024 through 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-markets-for-contract-pharmaceutical-manufacturing-research-and-packaging.htmlThe global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/drug-device-combinations-markets-report.htmlThe global market for drugs and diagnostics for hematological disorders is expected to grow from $131.2 billion in 2024 and is projected to reach $189.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/hematological-disorders-diagnostics-markets-report.htmlThe global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/gastrointestinal-therapeutics-markets-report.htmlThe global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/advanced-drug-delivery-systems-tech-markets-report.htmlThe global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/prostate-cancer-technologies-markets-report.htmlThe global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-markets-for-vaccine-technologies.htmlThe report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/chagas-disease-market.htmlThe global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/generic-drugs-markets-report.htmlThe global market for orphan drugs is expected to increase from $233.9 billion in 2023 to $415.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.2% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/orphan-drugs-market-report.htmlThe global market for autoimmune disease diagnostics is estimated to increase from $14.8 billion in 2023 to reach $17.9 billion by 2028, at a compound annual growth rate (CAGR) of 3.9% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/autoimmune-disease-diagnostics-report.htmlThis report provides an overview of the global market on anti-obesity drugs and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/anti-obesity-drugs-market.htmlThe global market for myasthenia gravis treatment is estimated to increase from $1.3 billion in 2023 to reach $2.2 billion by 2028, at a compound annual growth rate (CAGR) of 10.5% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/myasthenia-gravis-treatment-market.htmlThe global market for melanoma therapeutics is estimated to increase from $7.4 billion in 2023 to reach $12.1 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/melanoma-therapeutics-market.htmlThe global market for herbal medicine is expected to increase from $169.1 billion in 2023 to $279.8 billion by the end of 2028, with a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/herbal-medicine-market.htmlThe global market for HIV diagnostics and therapeutics is expected to increase from $30.4 billion in 2023 to $39.3 billion by the end of 2028, with compound annual growth rate (CAGR) of 5.3% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/diagnostics-therapeutics-for-HIV-global-markets.htmlThe global market for antithrombotic/anticoagulant drugs is estimated to grow from $31.6 billion in 2023 to reach $46.2 billion by 2028, at a compound annual growth rate (CAGR) of 7.9% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/antithrombotic-anticoagulant-drugs-markets-report.htmlThe global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/neurostimulation-markets.htmlThe global progressive ataxia and weakness disorders market reached $32.0 billion in 2022, should reach $35.1 billion by 2023 and $57.2 billion by 2028 with a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/progressive-ataxia-weakness-disorders.htmlThe global acute myeloid leukemia (AML) treatments market should reach $6.1 billion by 2028 from $3.8 billion in 2023 at a compound annual growth rate (CAGR) of 10.0% for the forecast period of 2023 to 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/acute-myeloid-leukemia-market.htmlThe global market for minimal residual disease testing is estimated to increase from $2.2 billion in 2023 to reach $4.3 billion by 2028, at a compound annual growth rate (CAGR) of 14.3% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/minimal-residual-disease-testing-market.htmlThis report provides its readers with the history, components, and types of Cannabis. It gives a brief picture of how cannabis is affecting different parts of the body and its use in different medical conditions.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/cannabis-medicinal-use-market.htmlThe global veterinary vaccines market reached $9.1 billion in 2022, should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/veterinary-vaccine-market.htmlThe global advanced wound management products market reached $10.7 billion in 2022 and should reach $15.3 billion by 2028, with a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2023-2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/advanced-wound-management.htmlThe global market for epigenetic therapeutics is estimated to increase from $6.8 billion in 2023 to reach $9.8 billion by 2028, at a compound annual growth rate (CAGR) of 7.7% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/global-epigenetic-therapeutics-market.htmlThe global market for regenerative medicine in bone and joint applications reached $9.6 billion in 2022. The market is estimated to increase from $10.7 billion in 2023 to $18.9 billion by 2028, at a compound annual growth rate (CAGR) of 12.1% from 2023 through 2028.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/regenerative-medicines-bone-joint-applications.htmlThe global antibiotics market reached $40.4 billion in 2022 and should reach $49.6 billion by 2027, with a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2022-2027.info@bccresearch.com https://www.bccresearch.com/market-research/pharmaceuticals/antibiotics-tech-market-report.html